Article Text

Download PDFPDF
Unusual association of diseases/symptoms
Massive haemoptysis in an intravenous drug user with infective tricuspid valve endocarditis
  1. Karin Anne Lydia Müller1,
  2. Christine Stefanie Zürn1,
  3. Htun Patrik1,
  4. Martin Heuschmid2,
  5. Jürgen Hetzel3,
  6. Andreas Henning1,
  7. Iris Irmgard Müller1,
  8. Georg Lamprecht4,
  9. Claus von Weyhern5,
  10. Christian Herdeg1,
  11. Gerhard Ziemer6,
  12. Meinrad Paul Gawaz1,
  13. Tobias Walker6
  1. 1Kardiologie, Medizinische Klinik Universitaetsklinikum Tuebingen, Tuebingen, Germany
  2. 2Radiologische Universitätsklinik, Tuebingen, Germany
  3. 3Pulmologie, Medizinische Klinik, Tuebingen, Germany
  4. 4Gastroenterologie, Medizinische Klinik, Tuebingen, Germany
  5. 5Pathologisches Institut, Tuebingen, Germany
  6. 6Klinik für Herz-, Thorax-, Gefäßchirurgie, Tuebingen, Germany
  1. Correspondence to Tobias Walker, tobias.walker{at}med.uni-tuebingen.de

Summary

Major causes of morbidity in intravenous drug users are infections. In infective endocarditis, the tricuspid valve is mainly involved. Masses can cause septic embolisms and, in rare cases, they are associated with mycotic aneurysms of pulmonary arteries that lead to severe haemorrhage.

We report the case of a young woman with a history of intravenous drug abuse and prolonged infective tricuspid valve endocarditis. Initially, echocardiography showed large masses on the anterior leaflet of the tricuspid valve and severe tricuspid regurgitation; blood cultures revealed staphylococcus and streptococcus species. Eight months after initial diagnosis, she presented with severe haemoptysis and fever. CT revealed a ruptured mycotic aneurysm of the right pulmonary artery. Lobectomy was performed immediately.

Postoperatively, the patient fully recovered. After continued antibiotic treatment, follow-up examinations showed negative echocardiographic findings and blood cultures results.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.